Singapore vs Switzerland: Hypertension: effective treatment coverage (controlled hypertension)
Singapore
38.8%
in 2019
Switzerland
37.9%
in 2019
Singapore rank
11th
Switzerland rank
12th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 38.8% against 37.9% in Switzerland, a difference of 0.9%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Switzerland ahead.
Singapore ranks 11th and Switzerland ranks 12th of 193 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.8% | 9.8% | 3.0% | Switzerland |
| 2000s | 16.4% | 20.6% | 4.2% | Switzerland |
| 2010s | 32.1% | 33.6% | 1.5% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Singapore or Switzerland?
- Singapore, at 38.8% against 37.9% in Switzerland as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Singapore and Switzerland?
- 0.9%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 30 years are reported by both, from 1990 to 2019.
- How do Singapore and Switzerland rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Singapore ranks 11th and Switzerland ranks 12th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.